Approval · Notice of Compliance 2237 · 2001
ALORA: Notice of Compliance 2237
Issued January 25, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2237
- Date
- January 25, 2001
- Company
- Schein Pharmaceutical Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Estrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALORA | 02237261 | — |
| ALORA | 02237260 | — |
| ALORA | 02237259 | — |